Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerro-alloy Re. Regulatory News (FAR)

Share Price Information for Ferro-alloy Re. (FAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.25
Bid: 6.00
Ask: 6.50
Change: 0.00 (0.00%)
Spread: 0.50 (8.333%)
Open: 6.25
High: 6.25
Low: 6.00
Prev. Close: 6.25
FAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Commercial Production & Sales of Calcium Molybdate

26 Oct 2020 07:00

RNS Number : 1247D
Ferro-Alloy Resources Limited
26 October 2020
 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 

Ferro-Alloy Resources Limited / EPIC: FAR.L/ Market: LSE/ Sector: Mining

26 October 2020

Ferro-Alloy Resources Limited ('the 'Company')

 

First Commercial Production and Sales of Calcium Molybdate

 

Ferro-Alloy Resources Limited (LSE: FAR), the vanadium mining and processing company with operations based in Southern Kazakhstan, is pleased to announce that it has made its first commercial production and sale of calcium molybdate.

Calcium molybdate (CaMoO4) is used in the production of ferromolybdenum, molybdenum-containing alloys, ceramics and direct alloying of steel and alloys with molybdenum in electric arc furnaces. The molybdenum content of calcium molybdate is sold on the pricing basis of molybdic oxide less a small discount.

The molybdenum will be extracted as a by-product from the same raw materials that the Company buys for the extraction of vanadium so there will be no additional raw-material costs. The quantity which the group can produce is dependent upon the grades of material being treated but is expected to be up to 14 tonnes of calcium molybdate (containing around 10 tonnes of molybdic oxide) per month. Some interruptions to production in the next few months are expected due to on-going Covid-19 restrictions and until the new connection to the adjacent high-voltage power line is made, expected in Spring of 2021, which is expected to significantly reduce down-time caused by power outages and instability. Nevertheless, the impact on revenues and earnings will be significant in the context of the current processing operation.

Although the immediate target is to produce calcium molybdate as a by-product from existing raw-materials, the Company now has the option to source molybdenum-bearing raw-materials with molybdenum is the primary metal where it is more profitable to do so.

The Company is in discussions with potential off-takers and expects to sign a long-term contract shortly.

 

 

Nick Bridgen, CEO, said: "I am extremely pleased with the speed at which we have been able to make our first commercial production and sale of calcium molybdate. This is another step in our plan for the development of the current small-scale operation while plans for the development of the Balasausqandiq project continue. It will bring a significant increase in revenue with only a small impact on costs and will be highly complementary to the record levels of production seen in recent months."

 

For further information, visit www.ferro-alloy.com or contact:

 

*ENDS*

 

Ferro-Alloy Resources Limited

Nick Bridgen, Chief Executive Officer info@ferro-alloy.com

 

Shore Capital (Broker)

Corporate Advisory: Toby Gibbs / Mark Percy / John More Tel: +44 (0)207 408 4090

Corporate Broking: Jerry Keen

 

VSA Capital (Financial Adviser) Tel: +44 (0)203 005 5000

Andrew Monk / Simon Barton

 

St Brides Partners Limited (Financial PR & IR Adviser)

Catherine Leftley / Megan Dennison Tel: +44 (0)207 236 1177

 

 

Further information about Ferro-Alloy Resources Limited

The Company's operations are all located at the Balasausqandiq Deposit in Kyzylordinskaya Oblast in the South of Kazakhstan. Currently the Company has two main business activities:

a) the high grade Balasausqandiq Vanadium Project (the "Project"); and

b) an existing profitable vanadium concentrate processing operation (the "Existing Operation")

Balasausqandiq is a very large deposit, with vanadium as the principal product, together with by-products of carbon, molybdenum, uranium, rare earth metals, potassium, and aluminium. Owing the nature of the ore, the capital and operating costs of development are very much lower than for other projects.

 

A reserve on the JORC 2012 basis has been estimated only for the first ore-body (of five) which amounts to 23 million tonnes, not including the small amounts of near-surface oxidised material which is in the Inferred resource category. In the system of reserve estimation used in Kazakhstan the reserves are estimated to be over 70m tonnes in ore-bodies 1 to 5 but this does not include the full depth of ore-bodies 2-5.

 

There is an existing concentrate processing operation at the site of the Balasausqandiq Deposit. The production facilities were originally created from a 15,000 tonnes per year pilot plant which was then adapted to treat low-grade concentrates and is now in the process of being expanded and further adapted to treat a wider variety of raw materials.

 

The Company has already completed the first steps of a development plan for the existing operation which is expected to result in annualised production capacity increasing gradually to around 1,500 tonnes of contained vanadium pentoxide. The development plan includes upgrades to infrastructure, an extension to the existing factory and the installation of equipment to increase the throughput and to add the facilities to convert AMV into vanadium pentoxide.

 

The strategy of the Company is to develop both the Existing Operation and the Project in parallel. Although they are located on the same site and use some of the same infrastructure, they are separate operations.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZMZGNKZGGZM
Date   Source Headline
1st Apr 20227:00 amRNSAppointment of Chief Financial Officer
10th Mar 202211:05 amRNSSecond Price Monitoring Extn
10th Mar 202211:00 amRNSPrice Monitoring Extension
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:01 amRNSPrice Monitoring Extension
2nd Mar 20222:10 pmRNSOperations Update
2nd Mar 20222:06 pmRNSSecond Price Monitoring Extn
2nd Mar 20222:00 pmRNSPrice Monitoring Extension
2nd Mar 202211:05 amRNSSecond Price Monitoring Extn
2nd Mar 202211:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSAppointment of Joint Broker
13th Jan 20224:40 pmRNSSecond Price Monitoring Extn
13th Jan 20224:35 pmRNSPrice Monitoring Extension
6th Jan 202212:00 pmRNSStatement re: Kazakhstan
3rd Dec 20211:30 pmRNSResult of AGM
1st Dec 20214:41 pmRNSSecond Price Monitoring Extn
1st Dec 20214:35 pmRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSBalasausqandiq Feasibility Study Update
10th Nov 20212:00 pmRNSNotice of AGM
10th Nov 20217:00 amRNSFirst sale of ferro-molybdenum
28th Sep 20217:00 amRNSInterim Results
22nd Sep 202111:15 amRNSProduction of ferro-molybdenum &vanadium pentoxide
22nd Sep 20217:00 amRNSProduction of ferro-molybdenum and ferro-vanadium
13th Sep 20217:00 amRNSElectrolyte Patent Received
24th Aug 20214:35 pmRNSPrice Monitoring Extension
28th Jun 202111:05 amRNSSecond Price Monitoring Extn
28th Jun 202111:00 amRNSPrice Monitoring Extension
28th Jun 20217:05 amRNSFurther Investment of US$7 million by Vision Blue
28th Jun 20217:00 amRNSFinal Results
7th Jun 20211:15 pmRNSVision Blue Investment Completion & Board Changes
2nd Jun 20219:05 amRNSSecond Price Monitoring Extn
2nd Jun 20219:00 amRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSVision Blue Further Investment & Board Changes
7th May 20212:05 pmRNSSecond Price Monitoring Extn
7th May 20212:00 pmRNSPrice Monitoring Extension
7th May 202111:05 amRNSSecond Price Monitoring Extn
7th May 202111:00 amRNSPrice Monitoring Extension
6th Apr 20219:05 amRNSSecond Price Monitoring Extn
6th Apr 20219:00 amRNSPrice Monitoring Extension
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:36 pmRNSPrice Monitoring Extension
30th Mar 20217:00 amRNSUpdated Investor Presentation
29th Mar 202111:05 amRNSSecond Price Monitoring Extn
29th Mar 202111:00 amRNSPrice Monitoring Extension
26th Mar 202111:05 amRNSSecond Price Monitoring Extn
26th Mar 202111:00 amRNSPrice Monitoring Extension
25th Mar 20216:20 pmRNSHolding(s) in Company
24th Mar 20217:00 amRNSResult of Placing
23rd Mar 20214:35 pmRNSProposed Placing of Ordinary Shares
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.